Levine Mark S.
- SEC CIK
- 0001617236
No open-market purchases or sales filed in the past year.
Current role at each company
- IMVT Immunovant, Inc.Chief Legal Officeras of Nov 22, 2024
- FLXN Flexion Therapeutics IncGeneral Counselas of Nov 19, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Levine Mark S. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IMVT Immunovant, Inc.
Chief Legal Officer17 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 (view filing) | Nov 20 | 2 days | Levine Mark S.Chief Legal Officer | SSale | −3.65K | $25.45 | −$92.9K | −1.1%319.2K after | |
| Oct 25, 2024 (view filing) | Oct 23 | 2 days | Levine Mark S.Chief Legal Officer | SSale | −4.36K | $29.53 | −$128.8K | −1.3%322.9K after | |
| Oct 18, 2024 (view filing) | Oct 16 | 2 days | Levine Mark S.Chief Legal Officer | SSale | −2.86K | $28.79 | −$82.3K | −0.9%327.2K after | |
| Aug 23, 2024 (view filing) | Aug 21 | 2 days | Levine Mark S.Chief Legal Officer | SSale | −3.29K | $31.86 | −$105.0K | −1.0%330.1K after | 2 lots |
| Jul 26, 2024 (view filing) | Jul 24 | 2 days | Levine Mark S.Chief Legal Officer | SSale | −4.01K | $27.76 | −$111.5K | −1.2%333.4K after | |
| Jul 19, 2024 (view filing) | Jul 17 | 2 days | Levine Mark S.Chief Legal Officer | SSale | −2.50K | $29.69 | −$74.4K | −0.7%337.4K after | 2 lots |
| May 24, 2024 (view filing) | May 22 | 2 days | Levine Mark S.Chief Legal Officer | SSale | −3.24K | $29.65 | −$96.1K | −0.9%339.9K after | |
| Apr 26, 2024 (view filing) | Apr 24 | 2 days | Levine Mark S.Chief Legal Officer | SSale | −3.96K | $28.90 | −$114.5K | −1.1%343.2K after | |
| Apr 19, 2024 (view filing) | Apr 17 | 2 days | Levine Mark S.Chief Legal Officer | SSale | −9.83K | $29.06 | −$285.6K | −2.8%347.1K after | 2 lots |
| Feb 23, 2024 (view filing) | Feb 22 | 1 day | Levine Mark S.Chief Legal Officer | SSale | −2.13K | $36.15 | −$77.1K | −0.7%302.0K after |
FLXN Flexion Therapeutics Inc
General Counsel1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 (view filing) | Jul 19 | 1 day | Levine Mark S.General Counsel | SSale | −3.94K | $6.45 | −$25.4K | −2.9%133.5K after |